Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 194

1.

Micafungin pharmacokinetic/pharmacodynamic adequacy for the treatment of invasive candidiasis in critically ill patients on continuous venovenous haemofiltration.

Maseda E, Grau S, Villagran MJ, Hernandez-Gancedo C, Lopez-Tofiño A, Roberts JA, Aguilar L, Luque S, Sevillano D, Gimenez MJ, Gilsanz F.

J Antimicrob Chemother. 2014 Jun;69(6):1624-32. doi: 10.1093/jac/dku013. Epub 2014 Feb 5.

PMID:
24505092
2.

Plasma and peritoneal fluid population pharmacokinetics of micafungin in post-surgical patients with severe peritonitis.

Grau S, Luque S, Campillo N, Samsó E, Rodríguez U, García-Bernedo CA, Salas E, Sharma R, Hope WW, Roberts JA.

J Antimicrob Chemother. 2015 Oct;70(10):2854-61. doi: 10.1093/jac/dkv173. Epub 2015 Jul 14.

PMID:
26180134
3.

Assessment of echinocandin regimens by pharmacokinetic/pharmacodynamic analysis against Candida spp. in paediatric patients.

Xu G, Zhu L, Liao S, Ge T, Yang J.

Int J Antimicrob Agents. 2015 Dec;46(6):631-41. doi: 10.1016/j.ijantimicag.2015.08.009. Epub 2015 Sep 21.

PMID:
26602452
4.

Use of pharmacokinetic-pharmacodynamic analyses to optimize therapy with the systemic antifungal micafungin for invasive candidiasis or candidemia.

Andes D, Ambrose PG, Hammel JP, Van Wart SA, Iyer V, Reynolds DK, Buell DN, Kovanda LL, Bhavnani SM.

Antimicrob Agents Chemother. 2011 May;55(5):2113-21. doi: 10.1128/AAC.01430-10. Epub 2011 Feb 7.

5.

Anidulafungin dosing in critically ill patients with continuous venovenous haemodiafiltration.

Aguilar G, Azanza JR, Carbonell JA, Ferrando C, Badenes R, Parra MA, Sadaba B, Navarro D, Puig J, Miñana A, Garcia-Marquez C, Gencheva G, Gutierrez A, Marti FJ, Belda FJ.

J Antimicrob Chemother. 2014 Jun;69(6):1620-3. doi: 10.1093/jac/dkt542. Epub 2014 Jan 26.

PMID:
24468868
6.

Efficacy of micafungin in invasive candidiasis caused by common Candida species with special emphasis on non-albicans Candida species.

Cornely OA, Vazquez J, De Waele J, Betts R, Rotstein C, Nucci M, Pappas PG, Ullmann AJ.

Mycoses. 2014 Feb;57(2):79-89. doi: 10.1111/myc.12104. Epub 2013 Jun 20.

PMID:
23786573
7.

Assessment of micafungin regimens by pharmacokinetic-pharmacodynamic analysis: a dosing strategy for Aspergillus infections.

Ikawa K, Nomura K, Morikawa N, Ikeda K, Taniwaki M.

J Antimicrob Chemother. 2009 Oct;64(4):840-4. doi: 10.1093/jac/dkp298. Epub 2009 Aug 21.

PMID:
19700475
8.

Optimizing Echinocandin dosing and susceptibility breakpoint determination via in vivo pharmacodynamic evaluation against Candida glabrata with and without fks mutations.

Lepak A, Castanheira M, Diekema D, Pfaller M, Andes D.

Antimicrob Agents Chemother. 2012 Nov;56(11):5875-82. doi: 10.1128/AAC.01102-12. Epub 2012 Sep 4.

9.

Candida and candidaemia. Susceptibility and epidemiology.

Arendrup MC.

Dan Med J. 2013 Nov;60(11):B4698. Review.

PMID:
24192246
10.

In vivo comparison of the pharmacodynamic targets for echinocandin drugs against Candida species.

Andes D, Diekema DJ, Pfaller MA, Bohrmuller J, Marchillo K, Lepak A.

Antimicrob Agents Chemother. 2010 Jun;54(6):2497-506. doi: 10.1128/AAC.01584-09. Epub 2010 Apr 12.

11.

Breakthrough invasive candidiasis in patients on micafungin.

Pfeiffer CD, Garcia-Effron G, Zaas AK, Perfect JR, Perlin DS, Alexander BD.

J Clin Microbiol. 2010 Jul;48(7):2373-80. doi: 10.1128/JCM.02390-09. Epub 2010 Apr 26.

12.

Pharmacokinetic/pharmacodynamic adequacy of echinocandins against Candida spp. in intensive care unit patients and general patient populations.

Yang Q, Wang T, Xie J, Wang Y, Zheng X, Chen L, Li Y, Meng T, Dong Y.

Int J Antimicrob Agents. 2016 May;47(5):397-402. doi: 10.1016/j.ijantimicag.2016.02.004. Epub 2016 Mar 15.

PMID:
27068676
13.

Single or 2-Dose Micafungin Regimen for Treatment of Invasive Candidiasis: Therapia Sterilisans Magna!

Gumbo T.

Clin Infect Dis. 2015 Dec 1;61 Suppl 6:S635-42. doi: 10.1093/cid/civ715. Review.

PMID:
26567282
14.

Outcomes with micafungin in patients with candidaemia or invasive candidiasis due to Candida glabrata and Candida krusei.

Shorr AF, Wu C, Kothari S.

J Antimicrob Chemother. 2011 Feb;66(2):375-80. doi: 10.1093/jac/dkq446. Epub 2010 Dec 8.

PMID:
21147825
15.

Pharmacodynamic target evaluation of a novel oral glucan synthase inhibitor, SCY-078 (MK-3118), using an in vivo murine invasive candidiasis model.

Lepak AJ, Marchillo K, Andes DR.

Antimicrob Agents Chemother. 2015 Feb;59(2):1265-72. doi: 10.1128/AAC.04445-14. Epub 2014 Dec 15.

16.

[Scientific evidence supporting the use of micafungin in the treatment of invasive candidiasis].

Montejo M, Quindós G.

Enferm Infecc Microbiol Clin. 2011 Mar;29 Suppl 2:15-22. doi: 10.1016/S0213-005X(11)70004-0. Review. Spanish.

PMID:
21420572
17.

EUCAST technical note on Candida and micafungin, anidulafungin and fluconazole.

Arendrup MC, Cuenca-Estrella M, Lass-Flörl C, Hope WW; European Committee on Antimicrobial Susceptibility Testing - Subcommittee on Antifungal Susceptibility Testing (EUCAST-AFST).

Mycoses. 2014 Jun;57(6):377-9. doi: 10.1111/myc.12170. Epub 2014 Jan 13.

PMID:
24417759
18.

Echinocandin use in the neonatal intensive care unit.

Caudle KE, Inger AG, Butler DR, Rogers PD.

Ann Pharmacother. 2012 Jan;46(1):108-16. doi: 10.1345/aph.1Q346. Epub 2011 Dec 20. Review.

PMID:
22190252
19.

Multiple-dose pharmacokinetics of anidulafungin during continuous venovenous haemofiltration.

Leitner JM, Meyer B, Fuhrmann V, Saria K, Zuba C, Jäger W, Böhmdorfer M, Thalhammer F.

J Antimicrob Chemother. 2011 Apr;66(4):880-4. doi: 10.1093/jac/dkq545. Epub 2011 Jan 22.

PMID:
21393208
20.

Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria.

Pfaller MA, Diekema DJ, Andes D, Arendrup MC, Brown SD, Lockhart SR, Motyl M, Perlin DS; CLSI Subcommittee for Antifungal Testing.

Drug Resist Updat. 2011 Jun;14(3):164-76. doi: 10.1016/j.drup.2011.01.004. Epub 2011 Feb 24. Review.

PMID:
21353623

Supplemental Content

Support Center